Evidence map›Paper›PMID 34610329›Full record

ArticleDevelopmental cell2021

Adaptations in Hippo-Yap signaling and myofibroblast fate underlie scar-free ear appendage wound healing in spiny mice.

Chris M Brewer, Branden R Nelson, Paul Wakenight, Sarah J Collins, Daryl M Okamura, Xiu Rong Dong, William M Mahoney, Aaron McKenna, Jay Shendure, Andrew Timms and 2 more

Open access · greenAbstract read
In one paragraph

Article in Developmental cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Fibroblasts in Scar Formation: Biology and Clinical Translation.Oxidative medicine and cellular longevity · 2022
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. GPCRs as key regulators in wound healing.Frontiers in cell and developmental biology · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Chris M BrewerDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA; Center for Developmental Biology & Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Branden R NelsonCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA. Electronic address: branden.nelson@seattlechildrens.org.
Paul WakenightCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Sarah J CollinsCenter for Developmental Biology & Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Daryl M OkamuraDepartment of Pediatrics, University of Washington, Seattle, WA 98195, USA; Center for Developmental Biology & Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Xiu Rong DongCenter for Developmental Biology & Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101, USA.
William M MahoneyDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
Aaron McKennaDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Jay ShendureDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, Seattle, WA 98195, USA.
Andrew TimmsCenter for Developmental Biology & Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Kathleen J MillenDepartment of Pediatrics, University of Washington, Seattle, WA 98195, USA; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA 98101, USA. Electronic address: kathleen.millen@seattlechildrens.org.
Mark W MajeskyDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA; Department of Pediatrics, University of Washington, Seattle, WA 98195, USA; Center for Developmental Biology & Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA 98101, USA. Electronic address: mwm84@uw.edu.
Seattle Children's Hospital · USUniversity of Washington · USCenter for Infectious Disease Research · USHoward Hughes Medical Institute · US

Funding

EXPERIMENTAL PATHOLOGY OF CARDIOVASCULAR DISEASET32HL007312 · NHLBI · UNIVERSITY OF WASHINGTON · PI MAJESKY, MARK W., SCHWARTZ, STEPHEN MARK · 1985 to 2019
$11.8M
Coordinating Unit for DiaCompU24DK115255 · NIDDK · AUGUSTA UNIVERSITY · PI MCINDOE, RICHARD A. · 2017 to 2020
$11.6M
Mechanisms of Brain Dysmorphology in MN1 C-Terminal Truncation Syndrome, a Novel Intellectual Developmental Disability Disorder P50HD103524 · NICHD · UNIVERSITY OF WASHINGTON · PI DANIEL DOHERTY · 2020 to 2026
$9.9M
Resident Progenitor Cells in the AdventitiaR01HL123650 · NHLBI · SEATTLE CHILDREN'S HOSPITAL · PI MAJESKY, MARK W. · 2014 to 2017
$2.4M
Acomys cahrinus: a new paradigm for kidney wound repairR01DK114149 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI MAJESKY, MARK W. · 2018 to 2020
$847k
Building transgenic tools in Acomys cahirinus, an emerging model for mammalian regenerative biology and healthy agingR21OD030107 · OD · SEATTLE CHILDREN'S HOSPITAL · PI MILLEN, KATHLEEN JOYCE · 2021 to 2022
$518k
New transgenic tools for mammalian fibrosis and regenerative repair researchR21OD023838 · OD · SEATTLE CHILDREN'S HOSPITAL · PI MILLEN, KATHLEEN JOYCE, NELSON, BRANDEN R · 2017 to 2018
$504k
Mechanisms of Retinal Ganglion Cell PatterningF32EY015631 · NEI · UNIVERSITY OF WASHINGTON · PI NELSON, BRANDEN R · 2004 to 2007
$142k
Howard Hughes Medical InstituteNEI NIH HHS F32 EY015631NEI NIH HHS L40 EY016882NHLBI NIH HHS R01 HL123650NHLBI NIH HHS T32 HL007312NICHD NIH HHS P50 HD103524NIDDK NIH HHS R01 DK114149NIDDK NIH HHS U24 DK115255NIH HHS R21 OD023838NIH HHS R21 OD030107
6 · The paper itself

Abstract

Spiny mice (Acomys cahirinus) are terrestrial mammals that evolved unique scar-free regenerative wound-healing properties. Myofibroblasts (MFs) are the major scar-forming cell type in skin. We found that following traumatic injury to ear pinnae, MFs appeared rapidly in both Acomys and mouse yet persisted only in mouse. The timing of MF loss in Acomys correlated with wound closure, blastema differentiation, and nuclear localization of the Hippo pathway target protein Yap. Experiments in vitro revealed an accelerated PP2A-dependent dephosphorylation activity that maintained nuclear Yap in Acomys dermal fibroblasts (DFs) and was not detected in mouse or human DFs. Treatment of Acomys in vivo with the nuclear Yap-TEAD inhibitor verteporfin prolonged MF persistence and converted tissue regeneration to fibrosis. Forced Yap activity prevented and rescued TGF-β1-induced human MF formation in vitro. These results suggest that Acomys evolved modifications of Yap activity and MF fate important for scar-free regenerative wound healing in vivo.

Indexed as

AnimalsCicatrixEarHippo Signaling PathwayMiceMurinaeMyofibroblastsSkinWound HealingYAP-Signaling ProteinsYap1 protein, mouseYAP-Signaling Proteinsadipocytesblastemachrondrogenesisfibrosishair follicle neogenesisHippo-Yapmelanocytesmyofibroblastregenerationreprogramming

Identifiers

PMID34610329
PMCPMC8623355
OpenAlexW3203540283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.